Description

Ceftazidime & Tobramycin for Injection – ERZID T Injection

Composition  – Cetazidime 1000 mg + Tobramycin 120 mg

Description:
Ceftazidime & Tobramycin for Injection is a potent antimicrobial combination formulated to provide broad-spectrum coverage against a wide range of Gram-negative and selected Gram-positive bacterial pathogens. Ceftazidime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Tobramycin, an aminoglycoside, disrupts bacterial protein synthesis. Together, they offer synergistic antibacterial activity, making the combination valuable in the management of severe and complicated bacterial infections.

Key Points:

• Dual Antibacterial Action – Combines two proven antibiotics with complementary mechanisms of action.
• Broad-Spectrum Coverage – Effective against a wide range of susceptible Gram-negative pathogens, including difficult-to-treat infections.
• Synergistic Bactericidal Effect – Enhances bacterial eradication through combined cell wall and protein synthesis inhibition.
• Suitable for Severe Infections – Commonly used in serious respiratory, urinary tract, intra-abdominal, and hospital-acquired infections.
• Trusted Parenteral Therapy – Provides reliable antimicrobial treatment in hospitalized and critically ill patients.

Targeted Specialities:
General Medicine
Pulmonology
Critical Care Medicine
Nephrology
Urology
General Surgery

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.